Viamonte 2278/80

PERSONAL INFORMATION
Name:
Nationality:
License Number:
María Otaola
Argentine.
111494
UNIVERSITARY DEGREES
1997 - 2002
2010-2011
University Attended: Medical Degree (M.D)
Universidad de Buenos Aires, Facultad de Medicina
Medical Diploma
Interstitial Lung Disease Fellowship
Buenos Aires British Hospital
Interstitial Lung Disease division
2007-2010
Pulmonary Residency
Hospital de Clínicas in Buenos Aires.
Respiratory Medicine
2003 - 2007
Residency
Cemic University Hospital
Internal Medicine.
CURRENT POSITION
Since 2013
Principal Investigator in the Clinical Research Department
Pneumology area
Centro de Investigaciones Metabólicas (CINME),
Buenos Aires, Argentina.
2012
Medical Doctor in the Clinical Research Department
Sub- Investigator, Pneumology area
Centro de Investigaciones Metabólicas (CINME),
Buenos Aires, Argentina.
Since 2010-
Pulmonary Staff in CEMIC University Hospital
Ppulmonary clinics, Pulmonary laboratory, bronchoscopy
1
FORMER POSITION
2007-2010
Higher education on Respiratory Medicine
Hospital de Clínicas
Medicine School Buenos Aires University
2009-2010
Higher education on Bronchoscopy
Argentine Association of Bronchoesophagology (AABE)
EDUCATION
Clinical Research
2010-
GCP for Investigational Site Staff Course, 2010. Pfizer
CLINICAL TRIALS: EXPERIENCE.
In the Past
2010-2011 B1321001 : A Phase 3, Multi-Center, Open Label Study To Evaluate The Long-Term
Safety Of Monotherapy Sitaxsentan Sodium And Combination Therapy With Sitaxsentan Sodium
And Sildenafil Citrate In Subjects With Pulmonary Arterial
2012 HZC115247:A 12-week study to evaluate the effect of fluticasone furoate (FF,
GW685698)/vilanterol (VI, GW642444) 100/25 mcg Inhalation Powder delivered once daily via a
Novel Dry Powder Inhaler (NDPI) on arterial stiffness compared with Tiotropium bromide 18 mcg
delivered once daily via a HandiHaler in subjects with Chronic Obstructive Pulmonary Disease
(COPD).
2012-2013: CQAB149B2401: A randomized, double-blind, parallel-group, 26-week study
comparing the efficacy and safety of indacaterol (Onbrez® Breezhaler® 150 μg o.d.) with
salmeterol/fluticasone propionate (Seretide® Accuhaler® 50 μg/500 μg b.i.d.) in patients with
moderate chronic obstructive pulmonary disease
INTERNATIONAL PRESENTATIONS
2010
“COPD in Buenos Aires: comunity screening during COPD global day”
Gene R, Apelbaum G, Boyeras I, Lonegro G, Aguirre R, Giovini V, Otaola
M, Rolando L
European Respiratory Society Annual Meeting, Barcelona
2
2011
“Rutine Endotracheal Aspirate (EA) as strategy for antibiotic
prescription in ventilator associated pneumonia (VAP)”
Rolando L, Aguirre R, Giovini V, Otaola M, Baillieau, N, Sarquis S., Sosa,
A., Luna CM.
American Thoracic Society Annual Meeting. New Orleans.
2009
“Effect of antimicrobial therapy (AMT) on endotracheal aspirate (ETA)
bacterial eradication and on the development of antimicrobial resistance,
ventilator-associated pneumonia (VAP) and mortality due to VAP.”
Otaola M, Baillieau, N, Sarquis S., Sosa, A., Luna CM.
American Thoracic Society Annual Meeting. San Diego
2007
“Increase in endotracheal tube (ETT) resistance after its use in ICU
patients under mechanical ventilation (MV): Forced oscillatory technique
(FOT) evaluation.”
Otaola M., Casaglia D., Chiapella M., Rios F., Guardia S., Fernández A.,
Apezteguia C., Sala.
European Respiratory Society Annual Meeting, Stocolm
NATIONAL PRESENTATIONS
2010
“Four year survival in patients with usual interstitial pneumonia (UIP)
secondary to idiopathic pulmonary fibrosis (IPF) and connective tissue
diseases”
M Otaola, S Quadrelli, G Tabaj, L Molinari, V Di Boscio
38th Argentine Association of Respiratory Medicine (AAMR) Conference,
Mar del Plata
2010
“Bronchoscopic diagnostic yield for infections in non –HIV
inmunocompromised patients in an University Hospital in Buenos Aires
city in the period 2000-2009”
VIII Southamerican Conference and XXVII Bronchology Argentinian
Conference in Buenos Aires, Argentina
Respiratory Endoschopy Southamerican Association (ASER) y Argentine
Association of Bronchoesophagology (AABE)
2009
“Pulmonary function tests and 5 year survival in a systemic sclerosis
cohort”
37th Argentine Association of Respiratory Medicine (AAMR) Conference,
Mar del Plata
2009
“Pulmonary involvment prevalence in a systemic sclerosis cohort”
37th Argentine Association of Respiratory Medicine (AAMR) Conference,
Mar del Plata
3
2009
“VEF1/VEF6 fix cut off values for obstruction diagnosis for the diferet
reference equations.”
37th Argentine Association of Respiratory Medicine (AAMR) Conference,
Mar del Plata
2008
“Impact of preventive treatment with antibiotics on the levels of
multiresistance in ventilatory associated pneumonia. “
2008
2008
“Early colonization of patients in mechanically assisted ventilation and the
influence of antibiotic preventive treatment”.
36th Argentine Association of Respiratory Medicine (AAMR) Conference, Mar
del Plata
“Bronchoscopic diagnostic yield for infections in non –HIV
inmunocompromised patients.”
36th Argentine Association of Respiratory Medicine (AAMR) Conference,
Mar del Plata
4